revenue guidance cut

Pomerantz Law Firm filed class action suit against Alight Inc. ($ALIT) following massive earnings miss, dividend elimination, and multibillion-dollar goodwill impairment in February 2026.

Option Care Health stock crashed over 30% after weak Q1 results and slashed full-year guidance due to chronic disease portfolio reset. Law firm investigates potential securities violations.

PROCEPT BioRobotics stock plunges 15% following disappointing earnings and cut guidance; securities fraud investigation underway seeking affected shareholders.

PROCEPT BioRobotics faces securities fraud probe after slashing 2026 revenue guidance by up to $40M, citing eliminated bulk discounts. Stock fell 15.12%.

Alight faces class action over allegedly misleading statements about growth. Company missed targets, cut guidance, lost CEO/CFO, and eliminated dividend.

Securities fraud lawsuit filed against Alight (ALIT) alleges executives misrepresented growth and sales execution while stock collapsed 56% over 15 months.

Class action lawsuit filed against $ALIT alleging executives made false statements about growth and cost cuts while concealing sales execution failures.

PROCEPT BioRobotics faces securities fraud investigation after missing earnings and cutting 2026 guidance by $20-30 million, triggering a 15% stock plunge.

Law firm launches investigation into $PRCT over alleged securities violations following disappointing earnings report and major revenue guidance cut.